摘要:
The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: wherein R represents a hydrogen atom, a lower alkyl group or a group forming a prodrug; one of Q and T represents a group represented by the general formula: (wherein P represents a hydrogen atom or a group forming a prodrug), while the other represents a lower alkyl group or a halo(lower alkyl) group; R2 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a halo(lower alkyl) group or a halogen atom; and with the proviso that P does not represent a hydrogen atom when R represents a hydrogen atom or a lower alkyl group, or pharmaceutically acceptable salts thereof, which exert an inhibitory activity in human SGLT2 and have an improved oral absorption, and therefore are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutically acceptable salts thereof, and pharmaceutical uses thereof.
摘要:
The present invention relates to a polyethylene-based stretched film having excellent Elmendorf tear strength and uniform stretchability. The invention relates to a polyethylene-based stretched film which is obtained by stretching a polyethylene-based resin, wherein (A-i) Em and Et, which represent the values of Elmendorf tear strength in the MD and TD directions, respectively, as measured in accordance with ASTM D1922, satisfy the following formulas 1, 2 and 3: 20≦Em[N/m]≦3000 (Formula 1) 20≦Et[N/m]≦3000 (Formula 2) 0.1≦(Em/Et)≦3 (Formula 3); (a-ii) the tensile initial modulus TM in the MD direction satisfies the following formula 4: 300≦TM[MPa]≦10000 (Formula 4); and (a-iii) the thickness is in the range of 5 to 150 μm, and is excellent in the stretch uniformity.
摘要:
The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group, a substituted or unsubstituted (lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.
摘要翻译:本发明涉及由以下通式表示的吡喃葡萄糖氧基苄基苯衍生物:其中R 1表示氢原子,羟基,取代或未取代的氨基,氨基甲酰基,取代或未取代的(低级烷基 )基团,取代或未取代的(低级烷氧基)基团等; R 2表示氢原子或低级烷基; 和R 3表示取代或未取代的(低级烷基)基团,取代或未取代的(低级烷氧基)基团,取代或未取代的(低级烷硫基)等,或其药学上可接受的盐,其中 在人SGLT2中具有抑制活性,并且可用作预防或治疗与高血糖相关的疾病如糖尿病,糖尿病并发症或肥胖症的药剂,包含其的药物组合物及其中间体。
摘要:
The present invention relates to glucopyranosyl-oxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group, a substituted or unsubstituted(lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.
摘要翻译:本发明涉及由以下通式表示的吡喃葡萄糖基 - 氧苄基苯衍生物:其中R 1表示氢原子,羟基,取代或未取代的氨基,氨基甲酰基,取代或未取代的(低级烷基) 取代或未取代的(低级烷氧基)等。 R 2表示氢原子或低级烷基; 和R 3表示具有抑制活性的取代或未取代的(低级烷基)基团,取代或未取代的(低级烷氧基)基团,取代或未取代的(低级烷硫基)等,或其药学上可接受的盐 人SGLT2,并且可用作预防或治疗与高血糖相关的疾病(如糖尿病,糖尿病并发症或肥胖症)的药剂,包含其的药物组合物及其中间体。
摘要:
An (meth)acryloyl group-modified ethylene-&agr;-olefin copolymer (A) which has (meth)acryloyl group as a the side-chain thereof, wherein the intrinsic viscosity [&eegr;] was 0.01 to 10 dl/g measured in decalin at a temperature of 135° C.; and a rubber composition which comprises said (meth)acryloyl group-modified ethylene-&agr;-olefin copolymer, a vulcanizing agent, and/or a crosslinking agent; in addition, a liquid curable rubber composition which comprises, component (A), reactive diluent (D), and if necessary, photopolymerization initiator (E).
摘要:
Disclosed is a polyethylene resin composition for heavy-duty packaging bag, which has a specific MFR, a specific density and a specific melt tension and which comprises (I) a linear low-density polyethylene resin prepared from ethylene and an .alpha.-olefin of 4 or more carbon atoms and having a specific MFR, a specific molecular weight distribution and a density of 0.900 to 0.918 g/cm.sup.3, (II) a linear medium or high-density polyethylene resin having a density of 0.935 to 0.970 g/cm.sup.3 and (III) a high-pressure low-density polyethylene resin having a density of 0.915 to 0.924 g/cm.sup.3, in a specific ratio of components. Also disclosed is a polyethylene resin film prepared from said composition. The composition is able to provide a film which is excellent in low-temperature properties such as low-temperature drop-bag strength and can be advantageously used for a heavy-duty packaging bag even in a cold district of below-freezing temperature. The polyethylene resin film exerts the above-mentioned effects.
摘要翻译:公开了一种用于重型包装袋的聚乙烯树脂组合物,其具有特定的MFR,比重密度和特定的熔体张力,并且包括(I)由乙烯和α-烯烃制备的线性低密度聚乙烯树脂 或更多的碳原子,并且具有特定的MFR,特定的分子量分布和0.900至0.918g / cm 3的密度,(II)密度为0.935至0.970g / cm3的线性介质或高密度聚乙烯树脂和( III)以特定比例的组分密度为0.915至0.924g / cm 3的高压低密度聚乙烯树脂。 还公开了由所述组合物制备的聚乙烯树脂膜。 该组合物能够提供低温下降袋强度等低温性能优异的膜,即使在低于冰点的低温区域也能够有利地用于重型包装袋。 聚乙烯树脂膜发挥上述效果。
摘要:
A visual communication is performed between a calling party and a called party through a plurality of channels. After the parties are connected through a first channel, an available telephone number of a second channel stored in a BAS control portion is read to a TNI control portion on each of the parties, and the TNI control portions of the parties exchange the available telephone numbers. Thereafter, when an incoming call having a telephone number is received through the second channel by a call control processing portion of the called party, the telephone number of the call is compared with the available telephone number of the second channel by an ICJ portion. To perform correct visual communication between parties, in cases where the telephone number of the call agrees with the available telephone number, the call is established by the call control processing portion, and image and audio signals are transmitted from the calling party to the called party through codec portions, multiplexing/demultiplexing portions and the first and second channels to perform a visual communication. In contrast, in cases where the telephone number of the call does not agree with the available telephone number, the second channel is released.
摘要:
The adhesiveness of a silicone-based coating film on a substrate to an overcoating layer, e.g., a photoresist layer, can be improved without causing cracks when the silicone-based coating film is subjected to a plasma treatment at a temperature of 120.degree. C. or below in an atmosphere of a gas mainly composed of oxygen. Similar conditions of plasma treatment are applicable when patterning of a silicone-based coating film is desired in a procedure comprising the steps of forming a photoresist layer thereon, patterning of the photoresist layer in a photolithographic method, selectively etching the silicone-based coating film with the patterned resist layer serving as a mask and removing the photoresist layer by the plasma treatment.
摘要:
A film suitable for an agricultural covering material is formed from a resin composition comprising a blend comprising (A) an ethylene/.alpha.-olefin random copolymer having a low melt flow rate and (B) an ethylene/.alpha.-olefin copolymer having a high melt flow rate. The random copolymer (A) has a density (D.sub.A) of 0.935 to 0.950 g/cc and the random copolymer (B) has a density (D.sub.B) of 0.905 to 0.935 g/cc, and the density (D.sub.B) of the random copolymer (B) satisfies the requirement of D.sub.B .ltoreq.0.9D.sub.A +0.09 in which D.sub.A stands for the density of the copolymer (A).